These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 15603304)
1. Dose fractionation and biological optimization in lung cancer. Trodella L; D'Angelillo RM; Ramella S; Ciresa M; Massaccesi M Rays; 2004; 29(3):319-26. PubMed ID: 15603304 [TBL] [Abstract][Full Text] [Related]
2. [Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer or head and neck cancer]. Plasswilm L Strahlenther Onkol; 2000 Dec; 176(12):583-4. PubMed ID: 11140154 [No Abstract] [Full Text] [Related]
3. Strategies for enhanced radiation delivery in patients with lung cancer. Mañon R; Mehta M Expert Opin Drug Deliv; 2005 Jan; 2(1):103-13. PubMed ID: 16296738 [TBL] [Abstract][Full Text] [Related]
4. [Current approaches to the use of radiotherapy in patients with non-small-cell lung cancer]. Goldobenko GV; Kanaev SV Vopr Onkol; 1998; 44(5):623-8. PubMed ID: 9884730 [No Abstract] [Full Text] [Related]
5. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer. Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134 [TBL] [Abstract][Full Text] [Related]
6. Long term results of CHART and weekly Paclitaxel in locally advanced non-small cell lung cancer. Oral EN Lung Cancer; 2005 Sep; 49(3):421-2. PubMed ID: 16102609 [No Abstract] [Full Text] [Related]
7. [Stage IIIB non-small cell lung cancer. Optimization of radiotherapy in lung cancer: some interesting questions to be solved]. Girard N; Mornex F Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S61-16S67. PubMed ID: 17268338 [TBL] [Abstract][Full Text] [Related]
8. Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). Atagi S; Kawahara M; Tamura T; Noda K; Watanabe K; Yokoyama A; Sugiura T; Senba H; Ishikura S; Ikeda H; Ishizuka N; Saijo N; Jpn J Clin Oncol; 2005 Apr; 35(4):195-201. PubMed ID: 15845568 [TBL] [Abstract][Full Text] [Related]
9. Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy. Graham PH; Clark C; Abell F; Browne L; Capp A; Clingan P; De Sousa P; Fox C; Links M Australas Radiol; 2006 Aug; 50(4):342-8. PubMed ID: 16884421 [TBL] [Abstract][Full Text] [Related]
10. Radiotherapy, local control and survival in lung cancer. Trodella L; Mantini G; Fontana A; Turriziani A; Balducci M Rays; 1998; 23(3):572-9. PubMed ID: 9932476 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant concurrent chemotherapy and radiotherapy in non-small cell lung cancer. Ramella S; Ciresa M; Massaccesi M; Franceschini G; D'Angelillo RM; Trodella L Rays; 2004; 29(4):439-43. PubMed ID: 15852733 [TBL] [Abstract][Full Text] [Related]
12. [Current progress in the radiotherapeutic treatment of non-small-cell lung cancer]. Van Houtte P Rev Med Brux; 1995; 16(1):14-9. PubMed ID: 7701161 [TBL] [Abstract][Full Text] [Related]
13. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233 [TBL] [Abstract][Full Text] [Related]
14. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448 [TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer. Iranzo V; Bremnes RM; Almendros P; Gavilá J; Blasco A; Sirera R; Camps C Lung Cancer; 2009 Jan; 63(1):63-7. PubMed ID: 18550204 [TBL] [Abstract][Full Text] [Related]
16. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer. Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402 [TBL] [Abstract][Full Text] [Related]
17. Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development. Guida C; Maione P; Rossi A; Bareschino M; Schettino C; Barzaghi D; Elmo M; Gridelli C Crit Rev Oncol Hematol; 2008 Dec; 68(3):222-32. PubMed ID: 18632283 [TBL] [Abstract][Full Text] [Related]
18. [Chemoradiation therapy: a model for treatment optimization in oncology]. Mornex F; Girard N; Van Houtte P Bull Cancer; 2006 Aug; 93(8):751-60. PubMed ID: 16935779 [TBL] [Abstract][Full Text] [Related]
19. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer]. Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022 [TBL] [Abstract][Full Text] [Related]
20. Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer. Thatcher N; Faivre-Finn C; Blackhall F; Anderson H; Lorigan P Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5051s-5056s. PubMed ID: 16000613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]